AU783539B2 - Treatment of diabetes with thiazolidinedione and sulphonylurea - Google Patents

Treatment of diabetes with thiazolidinedione and sulphonylurea Download PDF

Info

Publication number
AU783539B2
AU783539B2 AU15400/02A AU1540002A AU783539B2 AU 783539 B2 AU783539 B2 AU 783539B2 AU 15400/02 A AU15400/02 A AU 15400/02A AU 1540002 A AU1540002 A AU 1540002A AU 783539 B2 AU783539 B2 AU 783539B2
Authority
AU
Australia
Prior art keywords
compound
pharmaceutically acceptable
mg
acceptable derivative
tautomeric form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU15400/02A
Other versions
AU1540002A (en
Inventor
Stephen Alistair Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB9712854 priority Critical
Priority to GB9806710 priority
Priority to AU85392/98A priority patent/AU8539298A/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to AU15400/02A priority patent/AU783539B2/en
Publication of AU1540002A publication Critical patent/AU1540002A/en
Application granted granted Critical
Publication of AU783539B2 publication Critical patent/AU783539B2/en
Anticipated expiration legal-status Critical
Application status is Ceased legal-status Critical

Links